WallStreetZenWallStreetZen

NASDAQ: CELC
Celcuity Inc Stock Forecast, Predictions & Price Target

Analyst price target for CELC

Based on 4 analysts offering 12 month price targets for Celcuity Inc.
Min Forecast
$24.00+39.21%
Avg Forecast
$29.00+68.21%
Max Forecast
$40.00+132.02%

Should I buy or sell CELC stock?

Based on 4 analysts offering ratings for Celcuity Inc.
Strong Buy
Strong Buy
1 analysts 25%
Buy
3 analysts 75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CELC stock forecasts and price targets.

CELC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-12
lockedlocked$00.00+00.00%2024-03-28
lockedlocked$00.00+00.00%2024-03-28
lockedlocked$00.00+00.00%2024-02-22

1 of 1

Forecast return on equity

Is CELC forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36%

Forecast return on assets

Is CELC forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CELC revenue forecast

What is CELC's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$50.5M
Avg 2 year Forecast
$240.0M
Avg 3 year Forecast
$427.8M

CELC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CELC$17.24$29.00+68.21%Strong Buy
PHAT$8.97$21.33+137.83%Buy
VALN$7.58$21.50+183.53%Strong Buy
MESO$5.21N/AN/A
ANAB$19.87$44.63+124.58%Buy

Celcuity Stock Forecast FAQ

Is Celcuity Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: CELC) stock is to Strong Buy CELC stock.

Out of 4 analysts, 1 (25%) are recommending CELC as a Strong Buy, 3 (75%) are recommending CELC as a Buy, 0 (0%) are recommending CELC as a Hold, 0 (0%) are recommending CELC as a Sell, and 0 (0%) are recommending CELC as a Strong Sell.

If you're new to stock investing, here's how to buy Celcuity stock.

What is CELC's revenue growth forecast for 2026-2028?

(NASDAQ: CELC) Celcuity's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.06%.

Celcuity's revenue in 2024 is $0.On average, 3 Wall Street analysts forecast CELC's revenue for 2026 to be $1,536,359,904, with the lowest CELC revenue forecast at $741,533,472, and the highest CELC revenue forecast at $2,326,618,368. On average, 3 Wall Street analysts forecast CELC's revenue for 2027 to be $7,308,931,519, with the lowest CELC revenue forecast at $6,165,843,206, and the highest CELC revenue forecast at $8,860,335,264.

In 2028, CELC is forecast to generate $13,028,545,158 in revenue, with the lowest revenue forecast at $10,485,922,810 and the highest revenue forecast at $16,037,831,117.

What is CELC's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CELC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CELC's Price Target?

According to 4 Wall Street analysts that have issued a 1 year CELC price target, the average CELC price target is $29.00, with the highest CELC stock price forecast at $40.00 and the lowest CELC stock price forecast at $24.00.

On average, Wall Street analysts predict that Celcuity's share price could reach $29.00 by Apr 12, 2025. The average Celcuity stock price prediction forecasts a potential upside of 68.21% from the current CELC share price of $17.24.

What is CELC's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CELC) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.